USD 102.65
(2.7%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 1.24 Billion USD | -1.12% |
2022 | 1.25 Billion USD | 3.64% |
2021 | 1.21 Billion USD | 68.29% |
2020 | 719 Million USD | -32.87% |
2019 | 1.07 Billion USD | 238.92% |
2018 | 316 Million USD | -53.8% |
2017 | 684 Million USD | 48.7% |
2016 | 460 Million USD | 15.58% |
2015 | 398 Million USD | -19.92% |
2014 | 497 Million USD | -31.35% |
2013 | 724 Million USD | -37.21% |
2012 | 1.15 Billion USD | 13.93% |
2011 | 1.01 Billion USD | 62.18% |
2010 | 624 Million USD | 2112.9% |
2009 | -31 Million USD | -104.47% |
2008 | 693 Million USD | 8.62% |
2007 | 638 Million USD | -80.71% |
2006 | 3.3 Billion USD | 911.31% |
2005 | 327 Million USD | -6.3% |
2004 | 349 Million USD | 116.96% |
2003 | -2.05 Billion USD | -99.42% |
2002 | -1.03 Billion USD | -714.29% |
2001 | 168 Million USD | -77.81% |
2000 | 757 Million USD | 47.85% |
1999 | 512 Million USD | 99.22% |
1998 | 257 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 308 Million USD | -11.49% |
2024 Q1 | 348 Million USD | -26.74% |
2024 Q3 | 282 Million USD | -8.44% |
2023 Q1 | 352 Million USD | -4.35% |
2023 FY | 1.24 Billion USD | -1.12% |
2023 Q4 | 475 Million USD | 327.93% |
2023 Q3 | 111 Million USD | -63.25% |
2023 Q2 | 302 Million USD | -14.2% |
2022 Q3 | 329 Million USD | 20.07% |
2022 FY | 1.25 Billion USD | 3.64% |
2022 Q2 | 274 Million USD | -3.18% |
2022 Q1 | 283 Million USD | -35.97% |
2022 Q4 | 368 Million USD | 11.85% |
2021 Q1 | 288 Million USD | 29.73% |
2021 Q4 | 442 Million USD | 67.42% |
2021 Q3 | 264 Million USD | 22.22% |
2021 FY | 1.21 Billion USD | 68.29% |
2021 Q2 | 216 Million USD | -25.0% |
2020 Q4 | 222 Million USD | 11.56% |
2020 FY | 719 Million USD | -32.87% |
2020 Q2 | 101 Million USD | -48.73% |
2020 Q1 | 197 Million USD | 1.55% |
2020 Q3 | 199 Million USD | 97.03% |
2019 FY | 1.07 Billion USD | 238.92% |
2019 Q1 | 504 Million USD | 158.46% |
2019 Q2 | 182 Million USD | -63.89% |
2019 Q3 | 191 Million USD | 4.95% |
2019 Q4 | 194 Million USD | 1.57% |
2018 Q4 | 195 Million USD | -17.37% |
2018 Q3 | 236 Million USD | 15.12% |
2018 Q2 | 205 Million USD | 164.06% |
2018 Q1 | -320 Million USD | -280.79% |
2018 FY | 316 Million USD | -53.8% |
2017 Q2 | 164 Million USD | -2.38% |
2017 FY | 684 Million USD | 48.7% |
2017 Q4 | 177 Million USD | 1.14% |
2017 Q3 | 175 Million USD | 6.71% |
2017 Q1 | 168 Million USD | 35.48% |
2016 Q2 | 91 Million USD | -26.02% |
2016 FY | 460 Million USD | 15.58% |
2016 Q4 | 124 Million USD | 0.0% |
2016 Q3 | 124 Million USD | 36.26% |
2016 Q1 | 123 Million USD | -12.14% |
2015 Q4 | 140 Million USD | 35.92% |
2015 Q2 | 83 Million USD | 15.28% |
2015 FY | 398 Million USD | -19.92% |
2015 Q3 | 103 Million USD | 24.1% |
2015 Q1 | 72 Million USD | 350.0% |
2014 Q1 | 195 Million USD | -7.58% |
2014 FY | 497 Million USD | -31.35% |
2014 Q2 | 150 Million USD | -23.08% |
2014 Q3 | 147 Million USD | -2.0% |
2014 Q4 | 16 Million USD | -89.12% |
2013 FY | 724 Million USD | -37.21% |
2013 Q4 | 211 Million USD | 25.6% |
2013 Q3 | 168 Million USD | 1.2% |
2013 Q2 | 166 Million USD | -7.26% |
2013 Q1 | 179 Million USD | -57.88% |
2012 Q3 | 243 Million USD | -4.71% |
2012 Q2 | 255 Million USD | 10.87% |
2012 Q1 | 230 Million USD | -20.42% |
2012 FY | 1.15 Billion USD | 13.93% |
2012 Q4 | 425 Million USD | 74.9% |
2011 Q4 | 289 Million USD | -12.42% |
2011 FY | 1.01 Billion USD | 62.18% |
2011 Q1 | 193 Million USD | -33.9% |
2011 Q2 | 200 Million USD | 3.63% |
2011 Q3 | 330 Million USD | 65.0% |
2010 Q3 | 205 Million USD | 89.81% |
2010 Q1 | 79 Million USD | 216.0% |
2010 FY | 624 Million USD | 2112.9% |
2010 Q4 | 292 Million USD | 42.44% |
2010 Q2 | 108 Million USD | 36.71% |
2009 Q3 | -19 Million USD | 81.19% |
2009 Q4 | 25 Million USD | 231.58% |
2009 FY | -31 Million USD | -104.47% |
2009 Q1 | 64 Million USD | -72.29% |
2009 Q2 | -101 Million USD | -257.81% |
2008 FY | 693 Million USD | 8.62% |
2008 Q1 | 120 Million USD | -33.33% |
2008 Q4 | 231 Million USD | 36.69% |
2008 Q3 | 169 Million USD | -2.31% |
2008 Q2 | 173 Million USD | 44.17% |
2007 FY | 638 Million USD | -80.71% |
2007 Q2 | 123 Million USD | -18.0% |
2007 Q1 | 150 Million USD | 0.67% |
2007 Q3 | 185 Million USD | 50.41% |
2007 Q4 | 180 Million USD | -2.7% |
2006 Q3 | 227 Million USD | 97.39% |
2006 Q4 | 149 Million USD | -34.36% |
2006 Q2 | 115 Million USD | -95.92% |
2006 Q1 | 2.81 Billion USD | 11164.0% |
2006 FY | 3.3 Billion USD | 911.31% |
2005 Q4 | 25 Million USD | -75.96% |
2005 Q1 | 103 Million USD | 39.19% |
2005 Q3 | 104 Million USD | 9.47% |
2005 Q2 | 95 Million USD | -7.77% |
2005 FY | 327 Million USD | -6.3% |
2004 FY | 349 Million USD | 116.96% |
2004 Q1 | 71 Million USD | 446.15% |
2004 Q2 | 104 Million USD | 46.48% |
2004 Q3 | 100 Million USD | -3.85% |
2004 Q4 | 74 Million USD | -26.0% |
2003 Q3 | -1.55 Billion USD | -965.75% |
2003 Q1 | -369 Million USD | -56.36% |
2003 FY | -2.05 Billion USD | -99.42% |
2003 Q2 | -146 Million USD | 60.43% |
2003 Q4 | 13 Million USD | 100.84% |
2002 Q2 | -253 Million USD | 19.68% |
2002 FY | -1.03 Billion USD | -714.29% |
2002 Q4 | -236 Million USD | -3.51% |
2002 Q3 | -228 Million USD | 9.88% |
2002 Q1 | -315 Million USD | -329.93% |
2001 FY | 168 Million USD | -77.81% |
2001 Q4 | 137 Million USD | 162.56% |
2001 Q3 | -219 Million USD | -328.13% |
2001 Q2 | 96 Million USD | -37.66% |
2001 Q1 | 154 Million USD | -49.51% |
2000 Q3 | 155 Million USD | -6.63% |
2000 Q2 | 166 Million USD | 26.72% |
2000 Q1 | 131 Million USD | -10.27% |
2000 Q4 | 305 Million USD | 96.77% |
2000 FY | 757 Million USD | 47.85% |
1999 Q4 | 146 Million USD | 8.15% |
1999 FY | 512 Million USD | 99.22% |
1999 Q3 | 135 Million USD | -14.01% |
1999 Q2 | 157 Million USD | 112.16% |
1999 Q1 | 74 Million USD | 0.0% |
1998 FY | 257 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Charles River Laboratories International, Inc. | 474.62 Million USD | -161.259% |
Quest Diagnostics Incorporated | 854 Million USD | -45.199% |
Danaher Corporation | 4.76 Billion USD | 73.971% |
Enzo Biochem, Inc. | -26.07 Million USD | 4854.966% |
IQVIA Holdings Inc. | 1.35 Billion USD | 8.689% |
Laboratory Corporation of America Holdings | 418 Million USD | -196.651% |
Mettler-Toledo International Inc. | 788.77 Million USD | -57.205% |
Qiagen N.V. | 341.3 Million USD | -263.314% |
Revvity, Inc. | 693.09 Million USD | -78.908% |
Thermo Fisher Scientific Inc. | 5.99 Billion USD | 79.316% |
Waters Corporation | 642.23 Million USD | -93.076% |